Table 2. Correlation of biglycan mRNA expression in adipose tissues with metabolic parameters, abdominal fat distribution, and adipocyte size in study participants.

	VAT		SAT
	r	p	r	p
BMI	0.571	<0.001	0.508	<0.001
Systolic BP	0.335	0.001	0.292	0.005
Diastolic BP	0.245	0.020	0.205	0.052
Glucose	0.219	0.037	0.181	0.086
Insulin	0.380	<0.001	0.328	0.002
HOMA-IR	0.386	<0.001	0.330	0.002
Total cholesterol	0.244	0.020	0.143	0.176
HDL cholesterol	0.118	0.283	0.184	0.093
LDL cholesterol	0.369	0.001	0.371	<0.001
Triglyceride	0.344	0.004	0.290	0.016
hs-CRP	0.495	<0.001	0.410	<0.001
Leptin	0.495	<0.001	0.444	<0.001
Adiponectin	−0.339	0.002	−0.252	0.021
Adipocyte size*	0.310	0.021	0.331	0.014
Abdominal CT
TAT area	0.540	<0.001	0.343	0.015
VAT area	0.462	0.001	0.330	0.019
SAT area	0.507	<0.001	0.368	0.009
VSR	0.085	0.557	0.097	0.501

n = 91, r = Pearson correlation coefficient. ^*n = 55. BP, blood pressure; HOMA-IR, homeostasis model assessment of insulin resistance; hs-CRP, high-sensitive C-reactive protein; CT, computerized tomography; TAT, total adipose tissue; VAT, visceral adipose tissue; SAT, subcutaneous adipose tissue; VSR, the ratio of the visceral adipose tissue area to the subcutaneous adipose tissue area.